Research Progress
-
Nov 07, 2012Scientists from GIBH have made new achievements in the field of Adenovirus-Vectored VaccinationDr. Chen Ling is a distinguished research fellow at GIBH, CAS. Recently, his group (Dr Sun Caijun and Dr Feng Liqiang) discovered a new technology called AVIP (adenoviral vector-infected PBMC). This technology has been tested in a recogn...
-
Aug 15, 2012GIBH has developed a new chemical class of COX-2 inhibitorsThe international research team, composed of Dr. John J. Talley, Dr. Mark Obukowicz, Dr. Yanmei Zhang, Dr. Zhengchao Tu and Micky Tortorella have developed a new chemical entity as COX-2 inhibitors for the treatment of inflammation and i...
-
Aug 15, 2012GIBH has developed a new chemical class of COX-2 inhibitorsThe international research team, composed of Dr. John J. Talley, Dr. Mark Obukowicz, Dr. Yanmei Zhang, Dr. Zhengchao Tu and Micky Tortorella have developed a new chemical entity as COX-2 inhibitors for the treatment of inflammation and i...
-
Aug 14, 2012An efficient method for the synthesis of [1,2,3]triazolo[1,5-a]quinoxalin-4(5H)-ones and 1H-[1,2,3]triazolo[4,5-c]quinolin-4(5H)-onesDrs. CAI Qian and DING Ke Dings’ research teams at GIBH recently developed an efficient method for the synthesis of [1,2,3]triazolo[1,5-a]quinoxalin-4(5H)-ones and 1H-[1,2,3]triazolo[4,5-c]quinolin-4(5H)-ones through a novel copper-ca...
-
Jul 09, 2012Discover Cell RegenerationStem cell biology, regenerative biology and regenerative medicine are being served by a new open access journal from BioMed Central, called Cell Regeneration. Spearheaded by the Editor-in-Chief, Dr. Duanqing Pei, who is Director of the G...
-
Jul 09, 2012Discover Cell RegenerationStem cell biology, regenerative biology and regenerative medicine are being served by a new open access journal from BioMed Central, called Cell Regeneration. Spearheaded by the Editor-in-Chief, Dr. Duanqing Pei, who is Director of the G...